Tomoe Sano
Overview
Explore the profile of Tomoe Sano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishikawa T, Sato R, Jimbo R, Kobayashi Y, Sato T, Iwanaga A, et al.
Cancer Diagn Progn
. 2024 Sep;
4(5):611-616.
PMID: 39238622
Background/aim: Transarterial chemoembolization (TACE) is the standard treatment for patients with hepatocellular carcinoma in the intermediate stage; however, with advances in systemic therapy, the indications for TACE have gained significance....
2.
Ishikawa T, Sato R, Jimbo R, Kobayashi Y, Sato T, Iwanaga A, et al.
In Vivo
. 2024 Aug;
38(5):2501-2505.
PMID: 39187329
Background/aim: The prognosis of hepatocellular carcinoma (HCC) complicated with portal vein tumor thrombus (PVTT) is extremely poor. This study investigated whether local ablation-a curative treatment similar to resection-could improve the...
3.
Ishikawa T, Ohashi K, Kodama E, Kobayashi T, Azumi M, Nozawa Y, et al.
Gastro Hep Adv
. 2024 Aug;
1(3):431-436.
PMID: 39131674
Background And Aims: The prognosis of acute liver failure (ALF) treated with conservative therapy is extremely poor. Histologic diagnosis at the time ALF occurs provides important clues for determining the...
4.
Ishikawa T, Terai N, Sato R, Jimbo R, Kobayashi Y, Sato T, et al.
Intern Med
. 2024 Feb;
63(18):2491-2497.
PMID: 38346734
Objective Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) treatment guidelines recommend sodium glucose cotransporter 2 inhibitor (SGLT2I) and glucagon-like peptide-1 agonist (GLP-1A) therapy in patients with type 2 diabetes mellitus (T2DM)....
5.
Ishikawa T, Yamazaki S, Sato R, Jimbo R, Kobayashi Y, Sato T, et al.
Anticancer Res
. 2023 Dec;
44(1):361-368.
PMID: 38159993
Background/aim: Atezolizumab plus bevacizumab (Atez/Bev) therapy is extremely effective and has a high response rate in hepatocellular carcinoma (HCC) treatment. This study investigated the efficacy of adding locoregional therapy with...
6.
Sano T, Ishikawa T, Azumi M, Sato R, Jimbo R, Kobayashi Y, et al.
Medicine (Baltimore)
. 2023 Sep;
102(37):e35092.
PMID: 37713820
This study aimed to investigate the risk factors for difficult endoscopic hemostasis in patients with colonic diverticular bleeding and to evaluate the efficacy and safety of transcatheter arterial embolization (TAE)...
7.
Ishikawa T, Terai N, Igarashi T, Yamazaki S, Kobayashi T, Sato T, et al.
Clin Exp Hepatol
. 2023 Jul;
9(2):172-178.
PMID: 37502434
Aim Of The Study: Owing to the association between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia, there is a need for new treatment strategies to manage both conditions concomitantly. Our...
8.
Ishikawa T, Imai M, Sato R, Jimbo R, Kobayashi Y, Sato T, et al.
Anticancer Res
. 2023 Jul;
43(8):3647-3651.
PMID: 37500124
Background/aim: The standard of care for patients with colorectal cancer and liver metastases, who fail to respond to systemic chemotherapy has not yet been established. Therefore, we investigated the prognostic...
9.
Ishikawa T, Hasegawa I, Hirosawa H, Honmou T, Sakai N, Igarashi T, et al.
J Hepatocell Carcinoma
. 2023 Jun;
10:979-985.
PMID: 37377842
Background: Microwave ablation (MWA) is a standard percutaneous local therapy for hepatocellular carcinoma (HCC). Next-generation MWA is reported to create a more spherical ablation zone than radiofrequency ablation (RFA). We...
10.
Ishikawa T, Hasegawa I, Hirosawa H, Honmou T, Sakai N, Igarashi T, et al.
In Vivo
. 2023 Apr;
37(3):1047-1051.
PMID: 37103092
Background/aim: Ablating a spherical area during hepatocellular carcinoma ablation therapy is a very important issue. We aimed to determine the ablation area of bovine liver using various radiofrequency ablation (RFA)...